Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Philip Reigan and Sabrina Spencer.
|
|
Connection Strength |
|
 |
|
 |
|
0.242 |
|
|
|
-
Ill CR, Marikar NC, Nguyen V, Nangia V, Darnell AM, Vander Heiden MG, Reigan P, Spencer SL. BRAFV600 and ErbB inhibitors directly activate GCN2 in an off-target manner to limit cancer cell proliferation. bioRxiv. 2024 Dec 20.
Score: 0.242